Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q5399299> ?p ?o }
Showing triples 1 to 35 of
35
with 100 triples per page.
- Q5399299 subject Q7204516.
- Q5399299 subject Q8412954.
- Q5399299 subject Q8965786.
- Q5399299 subject Q9516482.
- Q5399299 abstract "Esreboxetine is a selective norepinephrine reuptake inhibitor which was under development by Pfizer for the treatment of neuropathic pain and fibromyalgia but failed to show significant benefit over currently available medications and was discontinued. It is the (+)-(S,S)-enantiomer of reboxetine and is even more selective in comparison.However, recently it has been shown that esreboxetine could be effective in fibromyalgia patients.".
- Q5399299 atcPrefix "none".
- Q5399299 casNumber "98819-76-2".
- Q5399299 fdaUniiCode "L8S50ZY490".
- Q5399299 iupacName "(2S)-2-[(S)-(2-ethoxyphenoxy)phenylmethyl]morpholine".
- Q5399299 pubchem "65856".
- Q5399299 thumbnail Esreboxetine.png?width=300.
- Q5399299 wikiPageWikiLink Q206921.
- Q5399299 wikiPageWikiLink Q418970.
- Q5399299 wikiPageWikiLink Q4914025.
- Q5399299 wikiPageWikiLink Q494483.
- Q5399299 wikiPageWikiLink Q540571.
- Q5399299 wikiPageWikiLink Q7204516.
- Q5399299 wikiPageWikiLink Q7825858.
- Q5399299 wikiPageWikiLink Q8412954.
- Q5399299 wikiPageWikiLink Q8965786.
- Q5399299 wikiPageWikiLink Q899668.
- Q5399299 wikiPageWikiLink Q9516482.
- Q5399299 atcPrefix "none".
- Q5399299 casNumber "98819".
- Q5399299 iupacName "-2".
- Q5399299 pubchem "65856".
- Q5399299 unii "L8S50ZY490".
- Q5399299 type ChemicalSubstance.
- Q5399299 type Drug.
- Q5399299 type ChemicalObject.
- Q5399299 type Thing.
- Q5399299 type Q8386.
- Q5399299 comment "Esreboxetine is a selective norepinephrine reuptake inhibitor which was under development by Pfizer for the treatment of neuropathic pain and fibromyalgia but failed to show significant benefit over currently available medications and was discontinued. It is the (+)-(S,S)-enantiomer of reboxetine and is even more selective in comparison.However, recently it has been shown that esreboxetine could be effective in fibromyalgia patients.".
- Q5399299 label "Esreboxetine".
- Q5399299 depiction Esreboxetine.png.